Essex Woodlands Management’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11M Hold
1,169,857
3.94% 3
2025
Q1
$6.34M Hold
1,169,857
1.83% 3
2024
Q4
$8.72M Sell
1,169,857
-381,664
-25% -$2.84M 2.01% 4
2024
Q3
$12.4M Hold
1,551,521
3.54% 3
2024
Q2
$13.5M Hold
1,551,521
4.4% 4
2024
Q1
$32.1M Sell
1,551,521
-786,265
-34% -$16.3M 9.3% 3
2023
Q4
$54M Sell
2,337,786
-1,153,135
-33% -$26.6M 13.37% 3
2023
Q3
$27.9M Sell
3,490,921
-700,000
-17% -$5.59M 24.59% 3
2023
Q2
$36.5M Hold
4,190,921
27.59% 3
2023
Q1
$12.3M Hold
4,190,921
7.13% 5
2022
Q4
$14.7M Hold
4,190,921
8.18% 4
2022
Q3
$33.2M Hold
4,190,921
13.7% 4
2022
Q2
$33M Hold
4,190,921
13.63% 3
2022
Q1
$50.9M Hold
4,190,921
12.31% 3
2021
Q4
$51.3M Hold
4,190,921
11.54% 3
2021
Q3
$43.7M Hold
4,190,921
9.69% 3
2021
Q2
$37.7M Hold
4,190,921
5.57% 4
2021
Q1
$42.6M Hold
4,190,921
6.66% 4
2020
Q4
$27.6M Sell
4,190,921
-1
-0% -$7 7.16% 4
2020
Q3
$21.8M Hold
4,190,922
11.58% 5
2020
Q2
$31.9M Hold
4,190,922
15.62% 3
2020
Q1
$42.7M Hold
4,190,922
27.52% 2
2019
Q4
$65M Hold
4,190,922
30.3% 1
2019
Q3
$75.9M Hold
4,190,922
47.25% 1
2019
Q2
$68.7M Hold
4,190,922
39.63% 1
2019
Q1
$75M Buy
4,190,922
+526
+0% +$9.42K 37.35% 1
2018
Q4
$79.2M Hold
4,190,396
31.54% 2
2018
Q3
$150M Buy
4,190,396
+1,643,357
+65% +$58.7M 31.11% 1
2018
Q2
$53M Buy
2,547,039
+1,686,407
+196% +$35.1M 12.3% 4
2018
Q1
$10.5M Buy
+860,632
New +$10.5M 2.3% 7